Guidelines & Procedures
Below are links to guidelines and procedures utilized by the Office for Research & Economic Development.
General
Pre-Award
- Budget Procedures for Grants and Contracts
- Colleges and Universities Rate Agreement
- Guidelines for Classification of Sponsored Projects
- Guidelines for Defining Teaching, Research, and Service
- Minimum Allowable PI Effort
- On/Off Campus Facilities & Administrative (F&A) Rates Application
- Data Management Plan
- Proposal Routing Policy FAQ
Post-Award
- Extra Compensation/Supplemental Pay Policy
- Effort Reporting Procedures
- Graduate Assistance in Areas of National Need (GAANN)
- How to Prevent and Resolve Deficit Budget Balances
- Participant Support Costs
- Procedure to Allocate Indirect Costs (IDC) to Divisions
- Tuition, Stipends, and Other Student Payments
- Data Management Plan Guidance
- SAE System Training Guide
- SAE Definitions
- SAE Frequently Asked Questions
- Cash Management
- Sponsored Closeout Process
Research Compliance
Animal Subjects (IACUC)
- Experimental and Humane Endpoints Guidelines for Laboratory and Clinical Animal Research
- Guideline for Alternative Literature Searching
- Guideline for Field Studies Involving Vertebrate Species
- Guideline for Non-Rodent Species Survival Surgery
- Guideline for Reporting the Unexpected Death of Adverse Event of a Vertebrate Animal
- Guideline for Rodent Analgesia for Survival Surgical Procedures
- Guideline for Rodent Euthanasia
- Guideline for Rodent Survival Surgery
- Policy on IACUC Functions
- Policy on Satellite Animal Facilities
- SOP for Animal Procurement
- SOP for Environmental Enrichment and Social Housing
- SOP for Fish Health Monitoring
- SOP for Rodent Health Monitoring
- SOP for Stabilization and Quarantine
Human Subject Research (IRB)
Responsible Conduct of Research
Conflict of Interest
- PUBLIC HEALTH SERVICE REGULATIONS – Responsibility of Applicants for Promoting Objectivity in Research for which PHS Funding is Sought (42 C.F.R. Part 50. Subpart F) Responsible Prospective Contractors (45 C.F.R. Part 94)
- NSF Guidance for Financial Conflict of Interest
- FDA Guidance – Financial Disclosure by Clinical Investigators